Action 455 TIANDA PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Tianda Pharmaceuticals Limited

Actions

455

KYG887471038

Temps Différé Hong Kong S.E.
Autres places de cotation
 03:48:43 29/04/2024 		Varia. 5j. Varia. 1 janv.
0,265 HKD 0,00% Graphique intraday de Tianda Pharmaceuticals Limited +1,92% +21,56%
26/03 Tianda Pharmaceuticals Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
21/03 Tianda Pharmaceuticals Limited fournit des prévisions de résultats consolidés pour l'année en cours, du 1er janvier 2023 au 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.
Tianda Pharmaceuticals Limited Announces Board Changes
Tianda Pharmaceuticals Limited Approves Final Dividend
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund
Beijing Tong Ren Tang Chinese Medicine’s CEO Redesignated; New CEO Named
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022
Tianda Pharmaceuticals to Set Up Additional Production Line to Meet Rising Medicine Demand
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 455
  4. Actualités Tianda Pharmaceuticals Limited
  5. Autres langues